首页> 外国专利> Compounds derived from urea, Kinase Inhibitors; Pharmaceutical composition that comprises; used in the treatment of diseases such as chronic Eosinophilic pneumonia, Asthma, COPD, Adult respiratory distress syndrome (ARDS), among others.

Compounds derived from urea, Kinase Inhibitors; Pharmaceutical composition that comprises; used in the treatment of diseases such as chronic Eosinophilic pneumonia, Asthma, COPD, Adult respiratory distress syndrome (ARDS), among others.

机译：衍生自脲，激酶抑制剂的化合物;药物组合物，其包含;用于治疗慢性嗜酸性粒细胞性肺炎，哮喘，COPD，成人呼吸窘迫综合征（ARDS）等疾病。

页面导航

摘要
著录项
相似文献

摘要

Compounds of formula (I) and pharmaceutically acceptable salts thereof: wherein R2, W, A, Y and R1 are as defined in the specification, are p38 MAPK inhibitors, and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.

机译：式（I）化合物及其药学上可接受的盐：其中R 2，W，A，Y和R 1如说明书中所定义，是p38 MAPK抑制剂，并且可用作抗炎剂，尤其用于治疗以下疾病：呼吸道疾病。

著录项

公开/公告号CL2014001486A1

专利类型
公开/公告日2014-11-14

原文格式PDF
申请/专利权人 CHIESI FARMACEUTICI S.P.A.;
展开▼

申请/专利号CL20140001486
发明设计人 VAN NIEL MONIQUE BODIL;RAY NOCHOLAS CHARLES;PANCHAL TERRY AARON;JENNINGS ANDREW STEPHEN ROBERT;ARMANI ELISABETTA;CRIDLAND ANDREW PETER;ALCARAZ LILIAN;HURLEY CHRISTOPHER;
展开▼

申请日2014-06-06
分类号A61K31/437;A61P11;C07D401/12;C07D403/12;C07D471/04;C07D519;
国家 CL
入库时间 2022-08-21 15:15:52

相似文献

专利
外文文献
中文文献